SRL
BEAM icon

Scientech Research LLC’s Beam Therapeutics BEAM Stock Holding History

Scientech Research LLC’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,580
Closed -$378K – 521
2025
Q3 		$378K Sell
15,580
-16,295
-51% -$324K 0.13% 322
2025
Q2 		$542K Buy
31,875
+12,025
+61% +$209K 0.13% 316
2025
Q1 		$388K Sell
19,850
-3,013
-13% -$78.9K 0.1% 372
2024
Q4 		$567K Buy
22,863
+5,192
+29% +$133K 0.16% 252
2024
Q3 		$433K Sell
17,671
-34,205
-66% -$884K 0.09% 399
2024
Q2 		$1.22M Buy
51,876
+32,469
+167% +$797K 0.25% 140
2024
Q1 		$641K Buy
19,407
+10,875
+127% +$339K 0.34% 72
2023
Q4 		$232K Buy
+8,532
New +$212K 0.23% 203

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Scientech Research LLC's BEAM Position: Q4 2025 in Review

Scientech Research LLC sold out of Beam Therapeutics (BEAM) in Q4 2025, closing a stake of 15,580 shares — an estimated $378K sold.

Scientech Research LLC first reported a position in BEAM in Q4 2023 and held it in 8 quarters. The position peaked at $1.22M in Q2 2024. 246 funds tracked by Wall St. Rank hold BEAM as of Q4 2025.

  • Scientech Research LLC reported no remaining Beam Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Scientech Research LLC sold 15,580 Beam Therapeutics shares in Q4 2025, an estimated $378K.
  • Scientech Research LLC first reported a position in Beam Therapeutics in Q4 2023 and held it in 8 quarters.
  • Scientech Research LLC's Beam Therapeutics position peaked at $1.22M in Q2 2024.
  • 246 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2025.

Based on Scientech Research LLC's 13F filing for Q4 2025, filed 17 Feb 2026.